Guidelines Pulmão

Molecular Testing for Selection of Lung Cancer Patients

Escrito por Carla Brito Lopes

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) have developed an evidence-based guideline which establishes recommendations for EGFR and ALK testing, helping to guide targeted therapies.

The GUIDELINE was released on April 3, 2013, in Archives of Pathology & Laboratory Medicine, Journal of Thoracic Oncology, and The Journal of Molecular Diagnostics.

The guideline provides answers to these important clinical questions:

  • When should testing be performed?
  • How should EGFR testing be performed?
  • How should ALK testing be performed?
  • Should other genes be routinely tested in lung cancer?
  • How should molecular testing of lung cancer be implemented?

The implementation of the CAP/IASLC/AMP guideline will ensure a uniform approach to the molecular testing of lung cancer and will improve the effectiveness of lung cancer treatment for patients.

Descarregar guideline aqui


Fontes:

1 – Arch Pathol Lab Med. 2013;137:828–860; doi: 10.5858/ arpa.2012-0720-OA

2 – http://www.cap.org/web/home/resources/cap-guidelines/current-cap-guidelines/molecular-testing-guideline-lung-cancer-patients?_afrLoop=487896998161711#!%40%40%3F_afrLoop%3D487896998161711%26_adf.ctrl-state%3D11qsijoptl_95

Sobre o autor

Carla Brito Lopes

Carla nasceu em Viana do Castelo em 1977. Licenciada em Anatomia Patológica, Citológica e Tanatológica pela Escola Superior de Tecnologia da Saúde em Lisboa. Concluiu a certificação em Laboratory Management pela ASCP (American Association of Clinical Pathology) em Setembro de 2016. Mestre em Genética Molecular e Biomedicina pela Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa. Trabalhou no Centro Hospitalar Lisboa Central entre 1998 e 2015, exercendo histopatologia e imunohistoquímica, sendo co-responsável pelo sector. Trabalha no Dr. Joaquim Chaves, Laboratório de Anatomia Patológica desde 2004 onde exerce funções de Coordenação Técnica e da Qualidade.

Deixe um comentário.